Browne Sean E reported grant involving 550,000 shares of Xtant Medical Holdings, Inc. at $0.00 for $0 on Aug 15, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
President and CEO
President and CEO
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
550,000Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
3,125,274Direct
Trade date
Aug 15, 2026Grant
Filed
Aug 18, 2026, 5:47 PM ET3-day reporting delay
Accession
0001790461-26-000001Code A · Transaction 3782
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 15, 2026Tax withholding10,605$0.31−$3,287.55Trade 3783
2 transaction rows in this filing. Joint filers share the same rows.

XTNT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
XTNT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +33%1w ago +33%1d ago −9.1%
Returns since7d −6.1%30d −3%90d180d1y

Footnotes in full

F1: These shares will vest with respect to 137,500 shares on each of August 15, 2027, August 15, 2028, August 15, 2029 and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock. F2: Includes an aggregate of 1,720,123 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates. F3: These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.